Anonymous ID: 7e31d0 May 20, 2022, 6:05 a.m. No.16309586   🗄️.is 🔗kun   >>9598

>>16309565

what a fuckin scam

 

This was where insurance came in, specifically a kind of pandemic insurance policy—for businesses, and perhaps even for countries—that would pay out as soon as an epidemic reached a certain threshold. In 2015, Metabiota had partnered with German reinsurance giant Munich Re and American insurance brokerage Marsh to develop and sell a policy specifically to guard large businesses against pandemics—to stanch the financial losses and keep them afloat. They'd launched it in mid-2018, a year and a half before the first Covid-19 cases appeared in China.

 

https://archive.ph/KY8zN#selection-839.0-839.246

Anonymous ID: 7e31d0 May 20, 2022, 6:09 a.m. No.16309598   🗄️.is 🔗kun   >>9624

>>16309586

Risk perceptions and behaviors of actors in the wild animal value chain in Kinshasa, Democratic Republic of Congo

 

Ashley Lucas ,

Charles Kumakamba,

Karen Saylors,

Erby Obel,

Reggiani Kamenga,

Maria Makuwa,

Catherine Clary,

Guy Miningue,

David J. McIver,

Christian E. Lange,

Placide Mbala Kingebeni,

Jean J. Muyembe-Tamfum

 

PLOS

 

Published: February 16, 2022

https://doi.org/10.1371/journal.pone.0261601

 

 

 

Funding: This study was supported by the generous support of the American people through the United States Agency for International Development (cooperative agreement number AID-OAA-A−14-00102). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. AL, KS, EO, RK, MM, CC, DJM, CEL, CK, PMK, GM were associated with the commercial entities Metabiota Inc., and Labyrinth Global Health. The funder, USAID, provided support to these entities in the form of salaries for authors AL, KS, EO, RK, MM, CC, DJM, CEL, CK, PMK, GM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.

Competing interests: All authors affiliated with Metabiota Inc., and Labyrinth Global Health assure that our association with this commercial entity does not alter our adherence to PLOS ONE policies on sharing data and materials.

 

https://archive.ph/MjxEu#selection-1611.0-1613.424

Anonymous ID: 7e31d0 May 20, 2022, 6:17 a.m. No.16309624   🗄️.is 🔗kun

>>16309598

Wasn't there a Crimean Hemoragic Fever Ukraine Biolabs were "studying"?

 

Metabiota in Africa

 

Metabiota’s Central African headquarters is located in Cameroon “managed under the leadership of local national Experts.” Metabiota has been operating in the region for the past two decades.

 

Metabiota has been implementing projects across Central Africa since its founding, including over $38.5M in USG grants and contracts executed over the past ten years. Their Cameroon office has long-lasting collaborative agreements with the Cameroon Ministry of Health; Ministry of Defence; Ministry of Livestock and Animal Husbandry; Ministry of Environment, Nature Protection, and Sustainable Development; Ministry of Forestry and Wildlife; and Ministry of Scientific Research and Innovation.

 

Metabiota’s Office Capacity Statements for Cameroon and DRC states that the Army Health Research Center (“CRESAR”):

 

“Was created in early 2000 as part of a partnership between Metabiota and the Cameroon Ministry of Defence, thanks to funding from the US Military’s HIV Research Program, the Walter Reed Army Institute of Research, Johns Hopkins University, the NIH, the Google Foundation, the Skoll Foundations, the French Research Institute for Development, and the CDC.

 

“Over the past twenty years, CRESAR has played an important role in assisting the Cameroon government in preparing for, detecting, and responding to key infectious disease outbreaks, including monkeypox, avian influenza, cholera, rabies, and human and animal influenza. Staffed by civilian and military workforce, CRESAR is a molecular biology and serology laboratory (BSL2).”

 

Metabiota was contracted by the Pentagon to perform work for DTRA before and during the Ebola crisis in West Africa and was awarded $3.1 million during the years 2012-2015 for work in Sierra Leone – one of the countries at the epicentre of the Ebola outbreak in 2014 and 2015.

 

A 17 July 2014 report drafted by the Viral Haemorrhagic Fever Consortium, accused Metabiota of failing to abide by an existing agreement on how to report test results and for bypassing the Sierra Leonean scientists working there. The report also raised the possibility that Metabiota was culturing blood cells at the lab, something the report said was dangerous, as well as misdiagnosing healthy patients. All of those allegations were denied by Metabiota.

 

However, a 2016 investigation by CBS found that WHO officials believe Metabiota screwed up the Ebola response in Africa and that there was “absolutely no control on what is being done.”

 

In part 2 we highlight who Metabiota’s investors are and its links to USAID’s PREDICT project, EcoHealth Alliance and Ukraine.

 

https://notaakhirzaman.com/9561/